Drug intelligence / Profile preview

Yangwei Granules

Development stage
Unknown
Lead developer
ChiaTai Qingchunbao Pharmaceutical
Administration
Oral
01

Overview

**Yangwei Granules** is an orally administered traditional Chinese medicine granule product used for chronic gastritis, including chronic atrophic gastritis. It is a multi-herb medicinal preparation rather than a single defined chemical entity; reported botanical components include *Astragali Radix*, *Codonopsis Radix*, and *Nardostachyos Radix et Rhizoma*, among other Chinese herbal materials. The product has been marketed by Chiatai Qingchunbao Pharmaceutical, with retail listings identifying a 5 g granule presentation. No validated single molecular target or target-specific mechanism of action has been established for the full formulation. ([jd.com](https://www.jd.com/jiage/16206a1feb3a47b07b60.html))

Other names
养胃颗粒
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)IL-6 (Interleukin 6)IL10 (Interleukin-10)PTPN11 (Tyrosine-protein phosphatase non-receptor type 11)PIK3CA (Phosphoinositide 3-kinase alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TNFA (Tumor necrosis factor alpha (soluble))TP53 (Cellular Tumor Antigen p53 R175H)TLR4 (Toll-like receptor 4)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Yangwei Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yangwei Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call